Wikisage, the free encyclopedia of the second generation, is digital heritage
Lewy body: Difference between revisions
Jump to navigation
Jump to search
(Hallervorden-Spatz_syndrome) |
(→Links: DOI) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Lewy body''' is a substance that stains eosin, and commonly found in Parkinson’s disease. | '''Lewy body''' is a substance that stains eosin, and commonly found in Parkinson’s disease. | ||
The main disease associated with the presence of Lewy bodies is [[Parkinson's disease]]. Lewy bodies are also present in [[neurons]] in [[dementia with Lewy bodies]] and the Lewy body variant of [[Alzheimer's disease]], as well as [[Hallervorden-Spatz_syndrome|Hallervorden-Spatz syndrome]]. | The main disease associated with the presence of Lewy bodies is [[Parkinson's disease]]. Lewy bodies are also present in [[neurons]] in [[dementia with Lewy bodies]] and the Lewy body variant of [[Alzheimer's disease]], as well as [[Hallervorden-Spatz_syndrome|Hallervorden-Spatz syndrome]]. | ||
<ref>https://simple.wikipedia.org/w/index.php?title=Lewy_body&oldid=4977934</ref><references/> | <ref>[https://simple.wikipedia.org/w/index.php?title=Lewy_body&oldid=4977934 Wikipedia(simple):Lewy body]</ref> | ||
{{wikidata|Q1822234}} | |||
==Links== | |||
[https://www.ncbi.nlm.nih.gov/pubmed/25713599 Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial] | |||
[http://onlinelibrary.wiley.com/doi/10.1002/ana.23557/pdf DOI: 10.1002/ana.23557] | |||
<references/> | |||
[[nl:Lewy-lichaampje]] | |||
Latest revision as of 01:00, 2 July 2017
Lewy body is a substance that stains eosin, and commonly found in Parkinson’s disease. The main disease associated with the presence of Lewy bodies is Parkinson's disease. Lewy bodies are also present in neurons in dementia with Lewy bodies and the Lewy body variant of Alzheimer's disease, as well as Hallervorden-Spatz syndrome. [1]
Links
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial DOI: 10.1002/ana.23557